Apolipoprotein A-V (APOA5) (N-Term) Peptide
APOA5
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5512631
Aperçu rapide pour Apolipoprotein A-V (APOA5) (N-Term) Peptide (ABIN5512631)
Antigène
APOA5
(Apolipoprotein A-V (APOA5))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Séquence
- TQARKGFWDY FSQTSGDKGR VEQIHQQKMA REPATLKDSL EQDLNNMNKF
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-APOA5 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
Apolipoprotein A-V (APOA5) peptide
APOA5 Reactivité: Humain Hôte: Synthetic BP, Imm
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- APOA5 (Apolipoprotein A-V (APOA5))
-
Sujet
-
The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified.
Alias Symbols: RAP3, APOAV
Protein Size: 366 -
ID gène
- 116519
-
NCBI Accession
- NM_001166598, NP_001160070
-
UniProt
- Q6Q788
Antigène
-
Vous êtes ici:
